Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

In a joint statement released by the American Medical Association

Doctors, Hospitals, Pharmacies Warned Not to Stockpile Meds

0
Professional societies issue stern warning not to inappropriately prescribe meds for COVID-19
Thirty-six months of treatment with immediate-release isradipine does not slow clinical progression of early-stage Parkinson disease

Isradipine Does Not Slow Early Parkinson Disease Progression

0
Change in total Unified Parkinson's Disease Rating Scale score similar for isradipine versus placebo
For women with early breast cancer receiving anthracyclines or trastuzumab

ACC: Statins Cut Heart Failure Risk in Early Breast Cancer Treatment

0
Risk for heart failure hospital visit declined with statins for women receiving anthracyclines, trastuzumab
Amongpatients with multidrug-resistant HIV-1 infection who have limited therapy options

Fostemsavir Active in Multidrug-Resistant HIV-1 Infection

0
Reduction in HIV-1 RNA level significantly greater for fostemsavir versus placebo in randomized cohort
For patients with transfusion-dependent β-thalassemia

Reduction Noted in Transfusion Burden With Luspatercept

0
Reduction seen with luspatercept versus placebo for patients with transfusion-dependent β-thalassemia
Following severe criticism

Gilead Backs Down on Special Designation for Possible COVID-19 Drug

0
Pharmaceutical company had asked the FDA to designate remdesivir an 'orphan drug'
One in 10 older adults hospitalized for common medical conditions are discharged with intensified diabetes medications

Many Older Adults Receive Inpatient Diabetes Rx Intensification

0
Benefit unlikely in half due to limited life expectancy or already being at their HbA1c goal
Certain types of EpiPens and their generic counterparts may fail or delay injection of lifesaving epinephrine for severe allergic reactions

FDA Warns of Defective EpiPen Dangers

0
Devices may activate prematurely if the blue safety release is removed using sideways force
A once-daily

Triple Therapy Cuts Mortality in Patients With Symptomatic COPD

0
All-cause mortality risk significantly lower for triple-drug regimen versus one of two dual-drug regimens
Inhibition of interleukin-1β with canakinumab is associated with reduced incident anemia as well as improved hemoglobin levels among patients with baseline anemia

Interleukin-1β Inhibition Linked to Reduced Incidence of Anemia

0
Among those with baseline anemia, hemoglobin levels improved with canakinumab versus placebo